Satu Oltedal

891 total citations
26 papers, 666 citations indexed

About

Satu Oltedal is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Satu Oltedal has authored 26 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Satu Oltedal's work include Cancer Genomics and Diagnostics (13 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Cells and Metastasis (9 papers). Satu Oltedal is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Cells and Metastasis (9 papers). Satu Oltedal collaborates with scholars based in Norway, United States and France. Satu Oltedal's co-authors include Oddmund Nordgård, Bjørnar Gilje, Kjersti Tjensvoll, Rune Smaaland, Morten Lapin, Reino Heikkilä, Hartwig Kørner, Jon Arne Søreide, Milind Javle and Herish Garresori and has published in prestigious journals such as PLoS ONE, Cancer Research and Annals of Surgery.

In The Last Decade

Satu Oltedal

26 papers receiving 660 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satu Oltedal Norway	16	476	406	201	170	143	26	666
Mai‐Britt W. Ørntoft Denmark	9	381 0.8×	446 1.1×	244 1.2×	190 1.1×	269 1.9×	20	685
Astrid J Bosma Netherlands	10	334 0.7×	296 0.7×	237 1.2×	159 0.9×	124 0.9×	11	629
Roberta Sgariglia Italy	14	317 0.7×	341 0.8×	225 1.1×	318 1.9×	160 1.1×	29	686
Margarita Reboredo Spain	13	304 0.6×	204 0.5×	206 1.0×	156 0.9×	70 0.5×	31	553
Alicia Abalo Spain	17	539 1.1×	609 1.5×	269 1.3×	259 1.5×	191 1.3×	27	881
Julianna Supplee United States	9	270 0.6×	485 1.2×	216 1.1×	334 2.0×	121 0.8×	13	708
Yuji Shimoda Japan	10	210 0.4×	229 0.6×	133 0.7×	132 0.8×	99 0.7×	26	410
Roz Brant United Kingdom	7	276 0.6×	413 1.0×	258 1.3×	398 2.3×	86 0.6×	7	694
Dineika Chandrananda United Kingdom	11	197 0.4×	525 1.3×	324 1.6×	201 1.2×	82 0.6×	16	653
Matilde Lambiase Italy	10	269 0.6×	317 0.8×	146 0.7×	271 1.6×	158 1.1×	19	515

Countries citing papers authored by Satu Oltedal

Since Specialization

Citations

This map shows the geographic impact of Satu Oltedal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satu Oltedal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satu Oltedal more than expected).

Fields of papers citing papers by Satu Oltedal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satu Oltedal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satu Oltedal. The network helps show where Satu Oltedal may publish in the future.

Co-authorship network of co-authors of Satu Oltedal

This figure shows the co-authorship network connecting the top 25 collaborators of Satu Oltedal. A scholar is included among the top collaborators of Satu Oltedal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satu Oltedal. Satu Oltedal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2023). Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. Clinical Cancer Research. 29(7). 1267–1278. 20 indexed citations

Tjensvoll, Kjersti, Satu Oltedal, Ingvild Dalen, et al.. (2023). Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging. Molecular Oncology. 17(9). 1857–1870. 5 indexed citations

Tjensvoll, Kjersti, Morten Lapin, Bjørnar Gilje, et al.. (2022). Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing. Scientific Reports. 12(1). 5816–5816. 2 indexed citations

Nordgård, Oddmund, Morten Lapin, Kjersti Tjensvoll, et al.. (2022). Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study. BMC Cancer. 22(1). 609–609. 2 indexed citations

Lapin, Morten, Satu Oltedal, Kjersti Tjensvoll, et al.. (2018). Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. Journal of Translational Medicine. 16(1). 300–300. 93 indexed citations

Oltedal, Satu, Hartwig Kørner, Kjersti Tjensvoll, et al.. (2018). The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer. Translational Oncology. 11(2). 436–443. 2 indexed citations

Oltedal, Satu, Ivar Skaland, Jodi Maple‐Grødem, et al.. (2018). Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics. BMC Gastroenterology. 18(1). 26–26. 16 indexed citations

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2017). Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer. 17(1). 390–390. 32 indexed citations

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2016). MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Scientific Reports. 6(1). 28929–28929. 34 indexed citations

10.

Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Molecular Oncology. 10(4). 635–643. 118 indexed citations

11.

Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Abstract 5241: Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients. Cancer Research. 75(15_Supplement). 5241–5241. 1 indexed citations

12.

Berg, Marianne, Oddmund Nordgård, Bjørn S. Nedrebø, et al.. (2013). Influence of Microsatellite Instability and KRAS and BRAF Mutations on Lymph Node Harvest in Stage I–III Colon Cancers. Molecular Medicine. 19(1). 286–293. 32 indexed citations

13.

Tjensvoll, Kjersti, Satu Oltedal, Reino Heikkilä, et al.. (2012). Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome. BMC Cancer. 12(1). 190–190. 29 indexed citations

14.

Tjensvoll, Kjersti, James M. Reuben, Satu Oltedal, et al.. (2012). miRNA expression profiling for identification of potential breast cancer biomarkers. Biomarkers. 17(5). 463–470. 8 indexed citations

15.

Nordgård, Oddmund, Satu Oltedal, Emiel A. M. Janssen, et al.. (2012). Comparison of a PNA Clamp PCR and an ARMS/Scorpion PCR Assay for the Detection of K-ras Mutations. Diagnostic Molecular Pathology. 21(1). 9–13. 14 indexed citations

16.

Nordgård, Oddmund, Satu Oltedal, Jon Arne Søreide, et al.. (2012). Prognostic Relevance of Occult Metastases Detected by Cytokeratin 20 and Mucin 2 mRNA Levels in Sentinel Lymph Nodes from Colon Cancer Patients. Annals of Surgical Oncology. 19(12). 3719–3726. 11 indexed citations

17.

Oltedal, Satu, Hartwig Kørner, Bjørnar Gilje, et al.. (2011). Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. International Journal of Colorectal Disease. 26(10). 1271–1277. 35 indexed citations

18.

Oltedal, Satu, Bjørnar Gilje, Hartwig Kørner, et al.. (2010). Detection of Occult Metastases in Sentinel Lymph Nodes From Colon Cancer Patients by K-ras Mutation Peptide Nucleic Acid Clamp PCR. Annals of Surgery. 251(6). 1087–1091. 11 indexed citations

19.

Nordgård, Oddmund, Satu Oltedal, Hartwig Kørner, et al.. (2009). The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR. International Journal of Colorectal Disease. 24(3). 261–268. 10 indexed citations

20.

Nordgård, Oddmund, Bjørnar Gilje, Fuad V. Shammas, et al.. (2007). Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients. Breast Cancer Research and Treatment. 108(2). 251–258. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact